Skip to content
TTM Q2 '26TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25
Profitability
Gross margin52.1%+5.4pp51.6%+7.0pp50.7%+8.1pp49.2%+8.7pp46.7%+8.4pp
Operating margin-33.9%+24.0pp-34.4%+28.8pp-36.2%+34.4pp-39.3%+40.3pp-57.9%+16.7pp
Net margin-19.8%+35.1pp-19.6%+40.2pp-20.6%+46.1pp-23.5%+51.1pp-55%+14.3pp
Returns
Return on equity-18.2%+20.1pp-16.8%+20.9pp-16.4%+21.7pp-17.6%+20.8pp-38.2%-7.8pp
Return on invested capital-36.4%+19.1pp-36%+20.2pp-38.6%+19.8pp-40.5%+20.2pp-55.4%-8.5pp
Efficiency
Asset turnover0.6×+0.1×0.6×+0.1×0.6×+0.1×0.6×+0.2×0.5×+0.2×
Liquidity
Current ratio2.7×-1.8×3.8×-1.2×3.6×-1.2×3.9×-1.0×4.5×-1.0×
Leverage
Debt-to-equity0.2×0.0×0.2×0.0×0.2×0.0×0.2×0.0×0.2×+0.1×
Per Share
Book value per share$7.380.0%$7.47-3.1%$7.91-2.9%$7.82-7.4%$7.38-23.9%
Valuation
Market capitalization$2.91B+24.4%$1.94B-29.7%$1.7B-35.3%$2.15B-24.6%$2.34B+18.7%
Price / sales7.1×+0.4×-3.4×4.5×-3.9×5.9×-3.7×6.7×-0.4×
Price / book6.4×+1.1×4.3×-1.8×3.6×-2.0×4.5×-1.3×5.3×+1.8×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Twist Bioscience Corporation's profit margins?
Twist Bioscience Corporation (TWST) runs a 52.1% gross margin and a -33.9% operating margin, with a -19.8% net margin.
Where do Twist Bioscience Corporation's ratios come from?
Every ratio is computed from Twist Bioscience Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.